News

Two Studies Find Beta-Blockers Help Combat Breast Cancer Progression


 

FROM JOURNAL OF CLINICAL ONCOLOGY

Dr. Barron and his colleagues declared that they had no financial disclosures relevant to their study, which was funded by the Irish government. Dr. Melhem-Bertrandt and colleagues said they had no financial disclosures relevant to their study, which was supported by a grant from the National Institutes of Health. Dr. Ganz and Dr. Cole, who were supported by the Breast Cancer Research Foundation, the Jonsson Comprehensive Cancer Center Foundation, Susan G. Komen for the Cure, and the National Cancer Institute, also declared that they had no relevant financial disclosures.

Pages

Recommended Reading

Intermittent Androgen Suppression Offers Small Gains for Prostate Cancer Patients
MDedge Internal Medicine
Genetic Marker Predicts Taxane-Induced Neuropathy
MDedge Internal Medicine
Sutent Approved for Pancreatic Neuroendocrine Tumors
MDedge Internal Medicine
Low Vitamin D Associated With Poor Prognostic Features in Breast Cancer
MDedge Internal Medicine
Point/Counterpoint: Does Surgery Improve Survival in Stage IV Breast Cancer?
MDedge Internal Medicine
Abiraterone Prolongs Survival in Castration-Resistant Prostate Cancer
MDedge Internal Medicine
Antiviral Cidofovir May Enhance Therapies for HPV-Related Cancers
MDedge Internal Medicine
Low Vitamin D Associated With Poor Prognostic Features in Breast Cancer
MDedge Internal Medicine
Sutent Approved for Pancreatic Neuroendocrine Tumors
MDedge Internal Medicine
PIVOT Trial: No Overall Benefit to Radical Prostatectomy for Localized Prostate Cancer
MDedge Internal Medicine